Literature DB >> 16773469

Intrastriatal administration of guanidinoacetate inhibits Na+, K+-ATPase and creatine kinase activities in rat striatum.

Alexandra I Zugno1, Emilene B S Scherer, Patrícia F Schuck, Diogo L Oliveira, Suzana Wofchuk, Clovis M D Wannmacher, Moacir Wajner, Angela T S Wyse.   

Abstract

Guanidinoacetate methyltransferase deficiency (GAMT deficiency) is an inherited neurometabolic disorder clinically characterized by epilepsy and mental retardation and biochemically by accumulation of guanidinoacetate (GAA) and depletion of creatine. Although this disease is predominantly characterized by severe neurological findings, the underlying mechanisms of brain injury are not yet established. In the present study, we investigated the effect of intrastriatal administration of GAA on Na+, K+-ATPase activity, total (tCK), cytosolic (Cy-CK), and mitochondrial (Mi-CK) creatine kinase (CK) activities in rat striatum. We verified that Na+, K+-ATPase, tCK, and Mi-CK activities were significantly inhibited by GAA, in contrast to Cy-CK which was not affected by this guanidino compound. Since these enzyme activities can be affected by reactive species, we also investigated the effect of intrastriatal administration of GAA on thiobarbituric acid reactive substances (TBARS), an index of lipid peroxidation in rats. We found that this metabolite significantly increased this oxidative stress parameter. Considering the importance of Na+, K+-ATPase and CK activities for brain metabolism homeostasis, our results suggest that the inhibition of these enzymes by increased intracerebral levels of GAA may contribute to the neuropathology observed in patients with GAMT-deficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773469     DOI: 10.1007/s11011-006-9003-8

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  37 in total

1.  A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera.

Authors:  B P HUGHES
Journal:  Clin Chim Acta       Date:  1962-09       Impact factor: 3.786

2.  Alanine reverses the inhibitory effect of phenylalanine and its metabolites on Na+,K(+)-ATPase in synaptic plasma membranes from cerebral cortex of rats.

Authors:  A T Wyse; M Wajner; A Brusque; C M Wannmacher
Journal:  Biochem Soc Trans       Date:  1995-05       Impact factor: 5.407

3.  Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study.

Authors:  O Braissant; H Henry; M Loup; B Eilers; C Bachmann
Journal:  Brain Res Mol Brain Res       Date:  2001-01-31

4.  A direct colorimetric assay for Ca2+ -stimulated ATPase activity.

Authors:  K M Chan; D Delfert; K D Junger
Journal:  Anal Biochem       Date:  1986-09       Impact factor: 3.365

5.  Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation.

Authors:  D H Jones; A I Matus
Journal:  Biochim Biophys Acta       Date:  1974-08-09

Review 6.  The creatine-creatine phosphate energy shuttle.

Authors:  S P Bessman; C L Carpenter
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 7.  Contributory mechanisms in the causation of neurodegenerative disorders.

Authors:  G J Lees
Journal:  Neuroscience       Date:  1993-05       Impact factor: 3.590

8.  Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain.

Authors:  E O'Gorman; G Beutner; T Wallimann; D Brdiczka
Journal:  Biochim Biophys Acta       Date:  1996-09-12

9.  Inhibition of creatine kinase activity in vitro by ethylmalonic acid in cerebral cortex of young rats.

Authors:  Patrícia F Schuck; Guilhian Leipnitz; César A J Ribeiro; Karina B Dalcin; Dênis R Assis; Alethea G Barschak; Vânia Pulrolnik; Clóvis M D Wannmacher; Angela T S Wyse; Moacir Wajner
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

10.  Activation of GABA(A) receptors by guanidinoacetate: a novel pathophysiological mechanism.

Authors:  Axel Neu; Henrike Neuhoff; Gerhard Trube; Susanne Fehr; Kurt Ullrich; Jochen Roeper; Dirk Isbrandt
Journal:  Neurobiol Dis       Date:  2002-11       Impact factor: 5.996

View more
  11 in total

1.  Creatine prevents the inhibition of energy metabolism and lipid peroxidation in rats subjected to GAA administration.

Authors:  Janaína Kolling; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2010-09-10       Impact factor: 3.584

2.  Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo.

Authors:  Angela M Sgaravatti; Alessandra S Magnusson; Amanda S Oliveira; Caroline P Mescka; Fernanda Zanin; Mirian B Sgarbi; Carolina D Pederzolli; Angela T S Wyse; Clóvis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2009-03-19       Impact factor: 3.584

3.  Guanidinoacetate decreases antioxidant defenses and total protein sulfhydryl content in striatum of rats.

Authors:  Alexandra I Zugno; Francieli M Stefanello; Emilene B S Scherer; Cristiane Mattos; Carolina D Pederzolli; Vanessa M Andrade; Clovis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho; Angela T S Wyse
Journal:  Neurochem Res       Date:  2008-03-15       Impact factor: 3.996

4.  Evidence for oxidative stress in tissues derived from succinate semialdehyde dehydrogenase-deficient mice.

Authors:  A Latini; K Scussiato; G Leipnitz; K M Gibson; M Wajner
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

5.  Guanidinoacetate administration increases acetylcholinesterase activity in striatum of rats and impairs retention of an inhibitory avoidance task.

Authors:  Alexandra I Zugno; Lenir O Pereira; Cristiane Mattos; Emilene B S Scherer; Carlos A Netto; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2008-04-24       Impact factor: 3.584

Review 6.  Mitochondrial dysfunction and psychiatric disorders.

Authors:  Gislaine T Rezin; Graziela Amboni; Alexandra I Zugno; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2008-11-01       Impact factor: 3.996

Review 7.  AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review.

Authors:  O Braissant; H Henry
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

8.  Effects in vitro of guanidinoacetate on adenine nucleotide hydrolysis and acetylcholinesterase activity in tissues from adult rats.

Authors:  Roselia Maria Spanevello; Angela Terezinha de Souza Wyse; Cinthia Melazzo Mazzanti; Roberta Schmatz; Naiara Stefanello; Jamile Fabbrin Gonçalves; Margarete Bagatini; Vanessa Battisti; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Journal:  Neurochem Res       Date:  2008-02-07       Impact factor: 3.996

9.  Guanidinoacetate inhibits glutamate uptake in rat striatum of rats at different ages.

Authors:  Alexandra I Zugno; Diogo L Oliveira; Emilene B S Scherer; Moacir Wajner; Susana Wofchuk; Angela T S Wyse
Journal:  Neurochem Res       Date:  2007-02-02       Impact factor: 4.414

10.  Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders.

Authors:  Lindsay C Burrage; Lillian Thistlethwaite; Bridget M Stroup; Qin Sun; Marcus J Miller; Sandesh C S Nagamani; William Craigen; Fernando Scaglia; V Reid Sutton; Brett Graham; Adam D Kennedy; Aleksandar Milosavljevic; Brendan H Lee; Sarah H Elsea
Journal:  Genet Med       Date:  2019-01-23       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.